Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials
Liver Failure, Acute
Pulmonary Disease, Chronic Obstructive
In this SOF-experienced, NS5A inhibitor-naïve population, which included participants with cirrhosis or HCV/HIV co-infection, high SVR12 rates were achieved.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency